Obagi Skintrinsiq Clarifiying Protocol
- Product NDC
- 62032-909
- 11-digit product format
- 620320909
- Labeler code
- 62032
- Product ID
- 62032-909_a9c17c57-a3af-43d6-9db3-56fb8e28894b
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- salicylic acid, titanium dioxide, and zinc oxide
- Dosage form
- KIT
- Labeler
- Obagi Cosmeceuticals LLC
- Application
- M020
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2021-08-01
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Package NDC | Code | Status | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|---|---|
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded product | product | I | Inactivated by FDA | 2ef7874e63bc… | 57b86245f4fa… | |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded package | package | 62032-909-09 | I | Inactivated by FDA | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded product | product | I | Inactivated by FDA | a1b67e2a42f9… | c4cf2c586c0d… | |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded package | package | 62032-909-09 | I | Inactivated by FDA | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded product | product | I | Inactivated by FDA | cfe11265f3b6… | 090c488252e2… | |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded package | package | 62032-909-09 | I | Inactivated by FDA | cfe11265f3b6… | 090c488252e2… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded product | product | I | Inactivated by FDA | cdf11ea48f46… | ba0047e9e063… | |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded package | package | 62032-909-09 | I | Inactivated by FDA | cdf11ea48f46… | ba0047e9e063… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded product | product | U | Excluded because listing certification expired | 302b2466d912… | e7b80fea0513… | |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded package | package | 62032-909-09 | U | Excluded because listing certification expired | 302b2466d912… | e7b80fea0513… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded product | product | U | Excluded because listing certification expired | ed331223b511… | 672a5bd82f5f… | |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded package | package | 62032-909-09 | U | Excluded because listing certification expired | ed331223b511… | 672a5bd82f5f… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded product | product | U | Excluded because listing certification expired | 0efc9e666f02… | f202fb6c5f17… | |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded package | package | 62032-909-09 | U | Excluded because listing certification expired | 0efc9e666f02… | f202fb6c5f17… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Obagi Skintrinsiq Clarifiying Protocol
- Listing expiration
- 2026-12-31
Harmonized RxCUI identifiers#
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 08ba9ea8-73fd-472b-9cc4-67df167352ec | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| dea2eded-d1e7-46bb-9a3d-f8dc20de6277 | Product name | 1 | 20190408 |
| 7792dadb-52b6-46b6-8fdf-80b1171065b5 | Product name | 1 | 20180810 |
| 9869efd7-d6dd-0665-5b67-53adbe6ef15e | Product name | 1 | 20140508 |
FDA-Initiated Inactive NDC Indexing#
| Effective | Related label |
|---|---|
| 2025-04-01 | Obagi ® Skintrinsiq™ Clarifiying Protocol Kit |
| 2025-01-30 | Obagi ® Skintrinsiq™ Clarifiying Protocol Kit |
| 2023-03-29 | Obagi ® Skintrinsiq™ Clarifiying Protocol Kit |
| 2023-01-30 | Obagi ® Skintrinsiq™ Clarifiying Protocol Kit |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 62032-612-04 | Obagi Skintrinsiq Clarifiying Protocol | 148 mL in 1 BOTTLE, PLASTIC | LIQUID | 148 mL | 20 mg in 1mL | 3 |
| 62032-811-09 | Obagi Skintrinsiq Clarifiying Protocol | 1 in 1 CARTON | LOTION | 15.6 g in 100g | 3 | |
| 62032-811-09 | Obagi Skintrinsiq Clarifiying Protocol | 85 g in 1 TUBE | LOTION | 85 g | 15.6 g in 100g | 3 |
| 62032-909-09 | Obagi Skintrinsiq Clarifiying Protocol | 1 in 1 BOX | KIT | 1 | 3 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 62032-909 | OBAGI SKINTRINSIQ CLARIFIYING PROTOCOL (SALICYLIC ACID, TITANIUM DIOXIDE, AND ZINC OXIDE) KIT [OBAGI COSMECEUTICALS LLC] | 3 | Current NDC, Legacy NDC, 4 package rows | 20250406_08ba9ea8-73fd-472b-9cc4-67df167352ec.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Eclipse Body Non Tinted | ZINC OXIDE | DENISE BELL SKIN CARE | 396f56df-d0de-1344-e063-6294a90a46ea | 2025-12-15 | M020 | |
| Solar Shield Tinted | TITANIUM DIOXIDE, ZINC OXIDE | DENISE BELL SKIN CARE | 396eb781-5947-3665-e063-6294a90a38dd | 2025-12-15 | M020 | |
| Sun Veil Illuminating Sunscreen SPF30 | ZINC OXIDE | Koco Life LLC | 46001097-540e-65da-e063-6294a90af299 | 2025-12-15 | Warnings | M020 |
| Mineral Primer tinted SPF40 | TITANIUM DIOXIDE, ZINC OXIDE | Oracle Esthetics, LLC | 3542d8d3-35a3-7d63-e063-6394a90a6fd1 | 2025-12-15 | M020 | |
| Mineral Primer non-tinted SPF40 | TITANIUM DIOXIDE, ZINC OXIDE | Oracle Esthetics, LLC | 354357de-1a85-3bdb-e063-6294a90aa9a2 | 2025-12-15 | M020 | |
| Mineral Primer tinted SPF40 | TITANIUM DIOXIDE, ZINC OXIDE | Oracle Esthetics, LLC | 35433254-1dc8-a8f3-e063-6394a90a29f0 | 2025-12-15 | M020 | |
| Sun Therapy Sunscreen | ZINC OXIDE | Skin Therapy Studio LLC | 3544916b-3f63-3a7a-e063-6394a90ae507 | 2025-12-15 | M020 | |
| Ultra Zinc Mineral Non Tinted | ZINC OXIDE | Skin Therapy Studio LLC | 3545d603-3d01-c51d-e063-6394a90a1599 | 2025-12-15 | M020 | |
| Sun Therapy Sunscreen | ZINC OXIDE | Skin Therapy Studio LLC | 357efafb-aa1c-0d69-e063-6394a90a5135 | 2025-12-15 | M020 | |
| Ultra Zinc Mineral Non Tinted | ZINC OXIDE | Skin Therapy Studio LLC | 35806102-6919-116f-e063-6294a90ad922 | 2025-12-15 | M020 | |
| Complexion Correction Primer Sunscreen clear | TITANIUM DIOXIDE, ZINC OXIDE | MCRAE MD MEDICAL LASER CENTER, A TEXAS PROFESSIONAL LIMITED LIABILITY COMPANY | 357eee3c-1c21-5efb-e063-6294a90a4bb7 | 2025-12-15 | M020 | |
| Complexion Correction Tinted Primer Sunscreen | TITANIUM DIOXIDE, ZINC OXIDE | MCRAE MD MEDICAL LASER CENTER, A TEXAS PROFESSIONAL LIMITED LIABILITY COMPANY | 357e75ec-473e-df76-e063-6294a90a70c7 | 2025-12-15 | M020 | |
| Complexion Correction Tinted Primer Sunscreen | TITANIUM DIOXIDE, ZINC OXIDE | MCRAE MD MEDICAL LASER CENTER, A TEXAS PROFESSIONAL LIMITED LIABILITY COMPANY | 357f2f62-904a-2234-e063-6394a90aee72 | 2025-12-15 | M020 | |
| Superscreen Daytime Mineral Sunscreen | ZINC OXIDE | MCRAE MD MEDICAL LASER CENTER, A TEXAS PROFESSIONAL LIMITED LIABILITY COMPANY | 357f915a-bd77-350b-e063-6294a90ad27f | 2025-12-15 | M020 | |
| Complexion Correction Primer Sunscreen clear | TITANIUM DIOXIDE, ZINC OXIDE | MCRAE MD MEDICAL LASER CENTER, A TEXAS PROFESSIONAL LIMITED LIABILITY COMPANY | 357ff025-84ad-6d77-e063-6394a90aad95 | 2025-12-15 | M020 | |
| Complexion Correction Tinted Primer Sunscreen | TITANIUM DIOXIDE, ZINC OXIDE | MCRAE MD MEDICAL LASER CENTER, A TEXAS PROFESSIONAL LIMITED LIABILITY COMPANY | 358021a2-235b-825b-e063-6394a90a76f5 | 2025-12-15 | M020 | |
| Superscreen Daytime Mineral Sunscreen | ZINC OXIDE | MCRAE MD MEDICAL LASER CENTER, A TEXAS PROFESSIONAL LIMITED LIABILITY COMPANY | 35805e66-18e6-0e45-e063-6294a90afe58 | 2025-12-15 | M020 | |
| Ultra Zinc Physical Defense | ZINC OXIDE | ATLANTA DERMOTOLOGY VEIN & RESEARCH CENTER | 35474ac4-8a9d-6a84-e063-6394a90a9bad | 2025-12-15 | M020 | |
| Ultra Zinc Physical Defense | ZINC OXIDE | ATLANTA DERMOTOLOGY VEIN & RESEARCH CENTER | 357e315e-8802-ad73-e063-6394a90a2495 | 2025-12-15 | M020 | |
| Tinted Physical Defense | TITANIUM DIOXIDE, ZINC OXIDE | ATLANTA DERMOTOLOGY VEIN & RESEARCH CENTER | 35477ed2-0875-58d5-e063-6294a90a3d5d | 2025-12-15 | M020 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 1235208 | CLENZIderm M.D. 2 % Pore Therapy Topical Solution | PSN | 08ba9ea8-73fd-472b-9cc4-67df167352ec | 3 |
| 251577 | salicylic acid 2 % Topical Solution | PSN | 08ba9ea8-73fd-472b-9cc4-67df167352ec | 3 |
| 1235208 | salicylic acid 20 MG/ML Topical Solution [Clenziderm] | SBD | 08ba9ea8-73fd-472b-9cc4-67df167352ec | 3 |
| 251577 | salicylic acid 20 MG/ML Topical Solution | SCD | 08ba9ea8-73fd-472b-9cc4-67df167352ec | 3 |
| 1235208 | Clenziderm 20 MG/ML Topical Solution | SY | 08ba9ea8-73fd-472b-9cc4-67df167352ec | 3 |
| 1235208 | Clenziderm M.D. 2 % Pore Therapy | SY | 08ba9ea8-73fd-472b-9cc4-67df167352ec | 3 |
| 251577 | salicylic acid 2 % Topical Solution | SY | 08ba9ea8-73fd-472b-9cc4-67df167352ec | 3 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 62032-612-04 | 62032061204 | 148 mL in 1 BOTTLE, PLASTIC | 148 ml | Historical | ||||
| 62032-811-09 | 62032081109 | 1 in 1 CARTON | Historical | |||||
| 62032-909-09 | 62032090909 | 1 KIT in 1 BOX (62032-909-09) * 148 mL in 1 BOTTLE, PLASTIC (62032-612-04) * 1 BOTTLE, PUMP in 1 CARTON / 48 g in 1 BOTTLE, PUMP * 1 TUBE in 1 CARTON (62032-811-09) / 85 g in 1 TUBE * 59 mL in 1 BOTTLE, PLASTIC * 60 mL in 1 BOTTLE, PLASTIC | 1 kit | 2021-08-01 | 0000-00-00 | No | No | Current |